Future of toxicology - Lipid peroxidation in the future: From biomarker to etiology

Chemical Research in Toxicology

Volumn 20, Issue 1, 2007, Pages 3-5

  Uchida, Koji ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; DNA ANTIBODY; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; ENANTIOMER; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

BIOLOGICAL MARKERS; EPITOPES; HUMANS; LIPID PEROXIDATION; TOXICOLOGY;

EID: 33846860816     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx600304n     Document Type: Review

References (16)

1. Halliwell, B., and Gutteridge, J. M. C. (1989) Free Radicals in Biology and Medicine, 2nd ed., Clarendon Press, Oxford.
2. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
3. Binder, C. J., Shaw, P. X., Chang, M. K., Boullier, A., Hartvigsen, K., Horkko, S., Miller, Y. I., Woelkers, D. A., Corr, M., and Witztum, J. L. (2005) The role of natural antibodies in atherogenesis. J. Lipid Res. 46, 1353-1363.
4. Wuttge, D. M., Bruzelius, M., and Stemme, S. (1999) T-cell recognition of lipid peroxidation products breaks tolerance to self proteins. Immunology 98, 273-279.
5. Palinski, W., and Witztum, J. L. (2000) Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med. 247, 371-380.
6. Palinski, W., Yla-Herttuala, S., Rosenfeld, M. E., Butler, S., Socher, S. A., Parthasarathy, S., Curtiss, L. K., and Witztum, J. L. (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Atherosclerosis 10, 325-335.
7. Scofield, R. H., Kurien, B. T., Ganick, S., McClain, M. T., Pye, Q., James, J. A., Schneider, R. I., Broyles, R. H., Bachmann, M., and Hensley, K. (2005) Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radical Biol. Med. 38, 719-728.
8. Uchida, K. (2003) 4-Hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog. Lipid Res. 42, 318-343.
9. Uchida, K. (2000) Role of reactive aldehyde in cardiovascular diseases. Free Radical Biol. Med. 28, 1685-1696.
10. Akagawa, M., Ito, S., Toyoda, K., Ishii, Y., Tatsuda, E., Yamaguchi, S., Shibata, T., Ishino, K., Kishi, Y., Adachi, T., Tsubata, T., Takasaki, Y., Hattori, N., Matsuda, T., and Uchida, K. (2006) Bispecific antibodies against modified protein and DNA with oxidized lipids. Proc. Natl. Acad. Sci. U.S.A. 103, 6160-6165.
11. Ito, S., Tatsuda, E., Ishino, K., Suzuki, K., Sakai, H., and Uchida, K. (2006) Crystallization and molecular-replacement studies of the monoclonal antibody mAbR310 specific for the (R)-HNE-modified protein. Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 62, 562-564.
12. Iuliano, L., Pratico, D., Ferro, D., Pittoni, V., Valesini, G., Lawson, J., Fitzgerald, G. A., and Violi, F. (1997) Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood 90, 3931-3935.
13. Grune, T., Michel, P., Sitte, N., Eggert, W., Albrecht-Nebe, H., Esterbauer, H., and Siems, W. G. (1997) Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radical Biol. Med. 23, 357-360.
14. Frostegard, J., Svenungsson, E., Wu, R., Gunnarsson, I., Lundberg, I. E., Klareskog, L., Horkko, S., and Witztum, J. L. (2005) Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 52, 192-200.
15. West, J. D., and Marnett, L. J. (2006) Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem. Res. Toxicol. 19, 173-194.
16. Liebler, D. C. (2006) The poisons within. Application of toxicology mechanisms to fundamental disease processes. Chem. Res. Toxicol. 19, 610-613.